Please use this identifier to cite or link to this item: http://hdl.handle.net/1942/24133
Full metadata record
DC FieldValueLanguage
dc.contributor.authorAlonso, Ariel-
dc.contributor.authorVAN DER ELST, Wim-
dc.contributor.authorMEYVISCH, Paul-
dc.date.accessioned2017-08-07T13:12:54Z-
dc.date.available2017-08-07T13:12:54Z-
dc.date.issued2017-
dc.identifier.citationSTATISTICS IN MEDICINE, 36(7), p. 1083-1098-
dc.identifier.issn0277-6715-
dc.identifier.urihttp://hdl.handle.net/1942/24133-
dc.description.abstractSeveral methods have been developed for the evaluation of surrogate endpoints within the causal-inference and meta-analytic paradigms. In both paradigms, much effort has been made to assess the capacity of the surrogate to predict the causal treatment effect on the true endpoint. In the present work, the so-called surrogate predictive function (SPF) is introduced for that purpose, using potential outcomes. The relationship between the SPF and the individual causal association, a new metric of surrogacy recently proposed in the literature, is studied in detail. It is shown that the SPF, in conjunction with the individual causal association, can offer an appealing quantification of the surrogate predictive value. However, neither the distribution of the potential outcomes nor the SPF are identifiable from the data. These identifiability issues are tackled using a two-step procedure. In the first step, the region of the parametric space of the distribution of the potential outcomes, compatible with the data at hand, is geometrically characterized. Further, in a second step, a Monte Carlo approach is used to study the behavior of the SPF on the previous region. The method is illustrated using data from a clinical trial involving schizophrenic patients and a newly developed and user friendly R package Surrogate is provided to carry out the validation exercise. Copyright (c) 2016 John Wiley & Sons, Ltd.-
dc.description.sponsorshipThe research leading to these results has received funding from the European Seventh Framework program [FP7 2007 - 2013] under grant agreement no. 602552.-
dc.language.isoen-
dc.publisherWILEY-
dc.rightsCopyright © 2016 John Wiley & Sons, Ltd-
dc.subject.othersurrogate endpoint; causal inference; sensitivity analysis; R package Surrogate-
dc.subject.othersurrogate endpoint; causal inference; sensitivity analysis; R package Surrogate-
dc.titleAssessing a surrogate predictive value: a causal inference approach-
dc.typeJournal Contribution-
dc.identifier.epage1098-
dc.identifier.issue7-
dc.identifier.spage1083-
dc.identifier.volume36-
local.format.pages16-
local.bibliographicCitation.jcatA1-
dc.description.notes[Alonso, Ariel] Katholieke Univ Leuven, I BioStat, B-3000 Leuven, Belgium. [Van der Elst, Wim] Univ Hasselt, I BioStat, B-3590 Diepenbeek, Belgium. [Meyvisch, Paul] Johnson & Johnson, Janssen Pharmaceut, Beerse, Belgium.-
local.publisher.placeHOBOKEN-
local.type.refereedRefereed-
local.type.specifiedArticle-
dc.identifier.doi10.1002/sim.7197-
dc.identifier.isi000395389100003-
item.fullcitationAlonso, Ariel; VAN DER ELST, Wim & MEYVISCH, Paul (2017) Assessing a surrogate predictive value: a causal inference approach. In: STATISTICS IN MEDICINE, 36(7), p. 1083-1098.-
item.fulltextWith Fulltext-
item.validationecoom 2018-
item.contributorAlonso, Ariel-
item.contributorVAN DER ELST, Wim-
item.contributorMEYVISCH, Paul-
item.accessRightsRestricted Access-
crisitem.journal.issn0277-6715-
crisitem.journal.eissn1097-0258-
Appears in Collections:Research publications
Files in This Item:
File Description SizeFormat 
alonso 1.pdf
  Restricted Access
Published version527.83 kBAdobe PDFView/Open    Request a copy
Show simple item record

SCOPUSTM   
Citations

6
checked on Sep 2, 2020

WEB OF SCIENCETM
Citations

10
checked on Sep 28, 2024

Page view(s)

50
checked on Sep 5, 2022

Download(s)

42
checked on Sep 5, 2022

Google ScholarTM

Check

Altmetric


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.